## Abstract Radioโlabelled coenzyme Q~10~, labelled at the 3โฒโposition with ^14^C, was synthesized starting from natural solanesol and ethyl [3โ^14^C] acetoacetate. The radiochemical yield was 8.0% from ethyl [3โ^14^C] acetoacetate. The specific radioactivity of the product was 44.8 ฮผCi, 1.66 MBq/m
Synthesis of deuterium-labelled coenzyme Q10
โ Scribed by Kimio Hamamura; Yoji Yamagishi; Shizumasa Kijima; Takeshi Suzuki; Yutaka Mori; Tetsuya Nakamura
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 107 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.587
No coin nor oath required. For personal study only.
โฆ Synopsis
Deuterium-labelled coenzyme Q 10 ([2-CD 3 -1 0 -CD 2 ]coenzyme Q 10 , coenzyme Q 10 -d 5 ) was synthesized by condensation of 2,3-dimethoxy-[5-CD 3 ]methyl-1, 4-hydroquinone with [1-CD 2 ]decaprenol. Five positions were selected for deuteration as replacement at these positions allowed examination of every step of the synthesis. This examination was carried out by a combination of 1 H-and 13 C-nuclear magnetic spectrometry and mass spectrometry. Further, these positions have been proved to be metabolically stable. This reagent makes simultaneous quantification of the source of coenzyme Q 10 (exogenously supplied or endogenously supplied) possible in biological samples by measurements on gas chromatography-mass spectrometry.
๐ SIMILAR VOLUMES
Medicine, 4 -1 Seiryo-cho, Sendai, 9 8 0 , Japan SUMMARY 11 [ CICoenzyme Q10 was synthesized by 0-methylation of 3demethyl coenzyme Ql0 with 11CH31. We have produced 1-4 mCi of [ Clcoenzyme Q10 with radiochemical yields of 6-16 % (based on trapping "CH I) in 35-50 min with radiochemical purities of
## Abstract Procedures for the preparation of trifluoperazine with two, four and six deuterium atoms are described. Deuterium was introduced in the propylpiperazine side chain by treatment of the appropriate amide with lithium aluminium deuteride. The isotopic purity of the products was greater tha
## Abstract Trantinterol, a selective ฮฒ~2~โadrenoceptor agonist, is currently in Phase II clinical trials for the treatment of asthma and bronchitis. The synthesis of deuteriumโlabelled trantinterol is described. The labelled trantinterol is used as an internal standard for the analysis and metabol
## Abstract This study describes the synthesis of deuteriumโlabelled etravirine. Etravirine labelled with six deuteriums was prepared in eight steps starting from phenol with excellent chemical purity and isotopic enrichment. It provides important internal standard for the clinical studies of etrav